FHD-286 is a potent and selective ATPase inhibitor of the SWI/SNF chromatin remodeling complex subunits BRM (SMARCA2) and BRG1 (SMARCA4). It serves as a valuable chemical probe for investigating BAF complex dysfunction in diseases, supporting both in vitro mechanistic studies and in vivo research in models of acute myeloid leukemia.
Molecular Weight:
562.66
Purity:
99.73% (May vary between batches)
CAS Number:
[2671128-05-3]
Formula:
C24H30N6O6S2
Target:
Epigenetic Reader Domain,OXPHOS
Application Notes:
Solubility: DMSO:245 mg/mL (435.43 mM)
* VAT and and shipping costs not included. Errors and price changes excepted